ReviewMetabolic brain disease2024

Exploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD.

Ali Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.